Dr. Oz vows to scrutinize Medicare Advantage as CMS head
3 Articles
3 Articles
CMS Nominee ‘Dr. Oz’ Grilled Over Potential Medicaid Cuts and Position on Medicare Negotiations at Confirmation Hearing - 340B Report
Mehmet Oz, President Donald Trump’s (R) nominee to lead the Centers for Medicare & Medicaid Services (CMS), faced persistent questioning—primarily from Senate Democrats—about whether he would oppose potential major Medicaid cuts, as well as Medicare drug price negotiations during his confirmation hearing on Friday.
UnitedHealth Group "thrilled" to have Medicare Advantage conversation
UnitedHealth Group is bracing for scrutiny from the Trump administration over the way it and other Medicare Advantage insurers bill the government, along with other cost-related topics, an executive at the health company told Axios. Why it matters: Mehmet Oz's characterization of the Medicare…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage